AI bio startup Boltz raises $110M Series A
LONDON — Less than a year after launching from stealth with $28 million, the AI bio startup Boltz has raised a $110 million Series A round, its leaders exclusively told Endpoints News. The ...
Boltz's leadership team (L-R): Jeremy Wohlwend, Gabriele Corso and Saro Passaro November 18, 2026 07:00 AM EST FinancingAI Exclusive: Boltz raises $110M as usage of its AI drug design software jumps 50-fold Andrew Dunn Senior Biopharma Correspondent LONDON — Less than a year after launching from stealth with $28 million, the AI bio startup Boltz has raised a $110 million … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that